5-11298111-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001332.4(CTNND2):​c.1628+48261A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.483 in 151,972 control chromosomes in the GnomAD database, including 17,985 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 17985 hom., cov: 32)

Consequence

CTNND2
NM_001332.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00300

Publications

6 publications found
Variant links:
Genes affected
CTNND2 (HGNC:2516): (catenin delta 2) This gene encodes an adhesive junction associated protein of the armadillo/beta-catenin superfamily and is implicated in brain and eye development and cancer formation. The protein encoded by this gene promotes the disruption of E-cadherin based adherens junction to favor cell spreading upon stimulation by hepatocyte growth factor. This gene is overexpressed in prostate adenocarcinomas and is associated with decreased expression of tumor suppressor E-cadherin in this tissue. This gene resides in a region of the short arm of chromosome 5 that is deleted in Cri du Chat syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
CTNND2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Illumina
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • benign adult familial myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.539 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001332.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNND2
NM_001332.4
MANE Select
c.1628+48261A>G
intron
N/ANP_001323.1
CTNND2
NM_001288715.1
c.1355+48261A>G
intron
N/ANP_001275644.1
CTNND2
NM_001364128.2
c.617+48261A>G
intron
N/ANP_001351057.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNND2
ENST00000304623.13
TSL:1 MANE Select
c.1628+48261A>G
intron
N/AENSP00000307134.8
CTNND2
ENST00000511377.5
TSL:1
c.1355+48261A>G
intron
N/AENSP00000426510.1
CTNND2
ENST00000513588.5
TSL:1
n.890+48261A>G
intron
N/AENSP00000421093.1

Frequencies

GnomAD3 genomes
AF:
0.482
AC:
73220
AN:
151854
Hom.:
17942
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.544
Gnomad AMI
AF:
0.365
Gnomad AMR
AF:
0.466
Gnomad ASJ
AF:
0.520
Gnomad EAS
AF:
0.235
Gnomad SAS
AF:
0.347
Gnomad FIN
AF:
0.480
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.477
Gnomad OTH
AF:
0.463
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.483
AC:
73331
AN:
151972
Hom.:
17985
Cov.:
32
AF XY:
0.477
AC XY:
35442
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.545
AC:
22571
AN:
41408
American (AMR)
AF:
0.466
AC:
7119
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.520
AC:
1806
AN:
3470
East Asian (EAS)
AF:
0.235
AC:
1215
AN:
5162
South Asian (SAS)
AF:
0.347
AC:
1671
AN:
4820
European-Finnish (FIN)
AF:
0.480
AC:
5067
AN:
10564
Middle Eastern (MID)
AF:
0.493
AC:
144
AN:
292
European-Non Finnish (NFE)
AF:
0.477
AC:
32419
AN:
67962
Other (OTH)
AF:
0.467
AC:
986
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1950
3900
5851
7801
9751
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.474
Hom.:
71987
Bravo
AF:
0.484
Asia WGS
AF:
0.324
AC:
1126
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
2.1
DANN
Benign
0.44
PhyloP100
0.0030
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2530215; hg19: chr5-11298223; API